Review Explores Telehealth for Substance Use Disorders
The use of telehealth for the treatment of substance use disorders (SUDs) is addressed in a review and clinical practice guideline.
The use of telehealth for the treatment of substance use disorders (SUDs) is addressed in a review and clinical practice guideline.
Experts discuss the advantages and disadvantages of treating patients with chronic pain via telemedicine.
Barney Stern, MD, and Andrew Russman, DO, share how the COVID-19 pandemic has changed neurology practice, including patient access to care, staffing shortages, and increased burnout.
A team of investigators assessed outcomes associated with a collaborative cardiovascular and psychiatry care approach to patients with heart failure and comorbid depression.
Investigators share outcomes from a virtual roundtable convened to discuss the effect of the COVID-19 pandemic on mental health and psychiatric care delivery.
Investigators participating in the TeleSCOPE study deployed a survey to evaluate the management of drug-induced movement disorders via telehealth during the COVID-19 pandemic.
Ikare Mood, Trauma, and Recovery Clinic created the Behavioral Health Integration Program, a care model that leverages telehealth visits and automation in assessments to reduce common obstacles to psychiatric care and offers targeted treatment for individuals reporting suicidal ideation.
The researchers sought to validate self-reported diagnosis of Parkinson disease in a study cohort, assess the validity of other self-reported health information, and evaluate the willingness of participants to participate in video-based research studies.
In their Public Opinion Poll, the APA collected information from 1000 US adults aged 18 and over between March 26, 2021, and April 5, 2021.
Researchers conducted a randomized clinical trial to determine whether targeted messaging could improve the return to in-person visits during the COVID-19 pandemic.